A total of 20 nations from Latin America, the Middle East, and Asia have already requested doses of Russia’s breakthrough coronavirus vaccine, which was confirmed to be registered on Tuesday by Russian President Vladimir Putin.
At a conference dedicated to the announcement of the vaccine’s registration, the CEO of the Russian Direct Investment Fund (RDIF) explained that it had already received orders for a billion doses.
“Together with our foreign partners, we are ready to produce more than 500 million doses of the vaccine per year,” Kirill Dmitriev explained. Everything produced in Russia will be used domestically, and doses for use in other countries will be made abroad.
According to Dmitriev, the RDIF is also working on a humanitarian aid program for developing countries, with the aim of making the Covid-19 vaccine available in states that can’t afford to make or buy their own.
Explaining that vaccination is an acute problem in the world’s poorest countries, Dmitriev said that the fund believes “people around the world should have equal access to a vaccine, regardless of their financial situation.”
On Tuesday, Russian President Vladimir Putin announced that the country had registered the world’s first Covid-19 vaccine. Named “Sputnik V,” the vaccine is due to enter mass production soon, and will be available to the general public from January 2021. Despite being registered, the vaccine will still go through more clinical trials in Russia and the Middle East.
